News
Aarti Drugs consolidated net profit declines 12.20% in the March 2026 quarter
16-May-2026 | 07:28
Sales rise 6.43% to Rs 720.30 crore
Net profit of Aarti Drugs declined 12.20% to Rs 55.19 crore in the quarter ended March 2026 as against Rs 62.86 crore during the previous quarter ended March 2025. Sales rose 6.43% to Rs 720.30 crore in the quarter ended March 2026 as against Rs 676.76 crore during the previous quarter ended March 2025.
For the full year,net profit rose 15.91% to Rs 194.92 crore in the year ended March 2026 as against Rs 168.16 crore during the previous year ended March 2025. Sales rose 7.47% to Rs 2565.31 crore in the year ended March 2026 as against Rs 2387.03 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 720.30 | 676.76 | 6 | 2565.31 | 2387.03 | 7 |
| OPM % | 13.30 | 13.79 | - | 12.05 | 12.03 | - |
| PBDT | 88.40 | 86.04 | 3 | 277.87 | 267.55 | 4 |
| PBT | 70.36 | 71.16 | -1 | 210.90 | 211.77 | 0 |
| NP | 55.19 | 62.86 | -12 | 194.92 | 168.16 | 16 |
Powered by Capital Market - Live News
